quinazolines has been researched along with Chickungunya Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, BN; Dash, PK; Parida, M; Rajaiya, J; Saha, A; Saxena, N | 1 |
| Abdelnabi, R; Amrun, SN; Delang, L; Leyssen, P; Neyts, J; Ng, LF | 1 |
2 other study(ies) available for quinazolines and Chickungunya Fever
| Article | Year |
|---|---|
Identification of 2,4-Diaminoquinazoline Derivative as a Potential Small-Molecule Inhibitor against Chikungunya and Ross River Viruses.
Topics: Antiviral Agents; Cell Line; Chikungunya Fever; Chikungunya virus; Humans; Quinazolines; Ross River virus; Virus Replication | 2023 |
Protein kinases C as potential host targets for the inhibition of chikungunya virus replication.
Topics: Acetophenones; Animals; Benzopyrans; Chikungunya Fever; Chikungunya virus; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Enzyme Inhibitors; Fibroblasts; Humans; Phorbol Esters; Protein Kinase C; Pyrroles; Quinazolines; Skin; Vero Cells; Virus Replication | 2017 |